ThreeD Capital (TSE:IDK) has released an update.
ThreeD Capital Inc., a Canadian venture capital firm, has finalized its investment in Sariel Diagnostics Corp. by purchasing 3.2 million shares at $0.05 each and compensating with 200,000 of its own shares. This strategic acquisition expands ThreeD’s portfolio in the junior resources and disruptive technologies sectors without incurring any additional commission or finder’s fees.
For further insights into TSE:IDK stock, check out TipRanks’ Stock Analysis page.